메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development

SINGAPORE, Sept. 27, 2025 -- The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded from September 24-26, 2025. The conference brought together leading biopharmaceutical companies and research institutions from Europe, North America, China, and the Asia-Pacific region. The conference aimed to facilitate exchanges and cooperation between Chinese and global biopharmaceutical enterprises and research institutions, and promote the application of advanced process technologies in the manufacturing of in
- 김갑성 기자
- 2025-09-27 10:45
COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients

[ 메디채널 김갑성 기자 ] Joint research achievement by Gemelli Hospital in Rome, COREE, COREE Pohang, and the Università Cattolica del Sacro Cuore SEOUL, South Korea, Sept. 26, 2025 -- COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity patients, in collaboration with Italian research teams. The company is led by Chairman Chong-Yoon Lim, who is also the largest shareholder of Dx&Vx. The announcement was made at the 38th Annual Workshop of the European Helicobacter & Microbiota S
- 김갑성 기자
- 2025-09-26 21:00
Asia Pacific Enterprise Awards (APEA) 2025 Taiwan Honors Outstanding Leaders and Enterprises Shaping the Future of Business

TAIPEI, Sept. 26, 2025 -- The Asia Pacific Enterprise Awards (APEA) recently celebrated Taiwan's visionary leaders and pioneering enterprises that are reshaping industries and championing sustainable growth. Organized by leading regional NGO Enterprise Asia, the prestigious Taiwan Chapter was staged on 25 September 2025 at the Grand Hyatt Taipei. The awards ceremony was graced by the presence of Dr. Eugene Chien, Advisor to Enterprise Asia and Ambassador-at large for Climate Change and Sustainability, Republic of China (Taiwan); Ms. Aznifah Ghani, President of the Malaysian Fri
- 황정호 기자
- 2025-09-26 18:16
Tescan acquires FemtoInnovations and launches Laser Technology Business Unit

TAIPEI, Sept. 26, 2025 -- Tescan Group today announced the acquisition of FemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicated Laser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The new unit expands Tescan's correlative and multimodal portfolio for semiconductor, biomedical device manufacturing, and advanced research markets. FemtoInnovations brings to TESCAN a unique and disruptive laser platform — technology already proven in demanding workflows and attracting strong inter
- 김갑성 기자
- 2025-09-26 14:47
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy

FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the treatment of IgA Nephropathy (IgAN), Kidney Disease: Improving Global Outcomes (KDIGO) 2025 clinical practice guideline for the management of IgA Nephropathy and Immunoglobulin A vasculitis. The updated guidelines define diagnostic criteria, treatment goals and treatm
- 김갑성 기자
- 2025-09-26 14:30
Get Race-Ready for KLSCM 2025 with Pantai Hospital Kuala Lumpur

A Hospital That Runs With You KUALA LUMPUR, Malaysia, Sept. 26, 2025 -- As the countdown begins to the Kuala Lumpur Standard Chartered Marathon (KLSCM) 2025, thousands of runners are training hard to hit their personal bests. But while most are focused on mileage, timing, and gear, Pantai Hospital Kuala Lumpur (PHKL) reminds us that true race-readiness starts from within. As a trusted healthcare institution for over 50 years, PHKL is not just treating illnesses, it's actively running with the community, through initiatives that prioritise prevention, sustainability, and
- 황정호 기자
- 2025-09-26 13:51
Tourism Malaysia and MHTC Bring Malaysia Fair 2025 to Surabaya A Celebration of Culture, Cuisine, Travel, and Healthcare Excellence

SURABAYA, Indonesia, Sept. 26, 2025 -- Tourism Malaysia, in collaboration with the Malaysia Healthcare Travel Council (MHTC), proudly presents Malaysia Fair 2025—a four-day celebration of Malaysia's culture, cuisine, tourism, and healthcare excellence. Taking place at Pakuwon Mall, Surabaya from 25 to 28 September 2025, the event marks the first-ever partnership between Tourism Malaysia and MHTC in support of Visit Malaysia 2026 (VM2026) and the Malaysia Year of Medical Tourism 2026 (MYMT2026) campaigns. Malaysia Fair 2025 positions Malaysia as both a premier leisure destinatio
- 김갑성 기자
- 2025-09-26 09:45
Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida

[ 메디채널 김갑성 기자 ] Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New headquarters designed to support innovation, collaboration and growth TAMPA, Fla., Sept. 26, 2025 -- Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced the opening of its new global corporate headquarters in Tampa, Fla. The state-of-the-art site has been designed to showcase innovation, collaboration and excellence, supporting the Company's commitment to drivi
- 김갑성 기자
- 2025-09-26 09:00
Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth

BEIJING, SHANGHAI and BOSTON, Sept. 26, 2025 -- Jacobio Pharmaceuticals (1167.HK) today announced that its Chairman and Chief Executive Officer, Dr. Yinxiang Wang, together with concerted parties, have recently increased their shareholding in the Company by 11.06 million shares, representing a total investment of approximately HK$96.34 million. This action underscores their strong confidence in the Company's long-term growth prospects. In addition, the Company's share repurchase plan with an upper limit of HK$100 million, which was approved by the Board in July 2025, has already led to
- 김갑성 기자
- 2025-09-26 08:47
Building a National Lung Cancer Screening Model with AI: Early Lessons from Australia

BRISBANE, Australia and SEOUL, South Korea, Sept. 26, 2025 -- Coreline Soft announced today it will host an international webinar on Tuesday, October 14, sharing firsthand experiences and insights from the National Lung Cancer Screening Program (NLCSP) in Australia. The event, presented in collaboration with Lungscreen Australia, will explore the theme: "Building a National Model for Lung Cancer Screening in Australia." Australia officially launched its NLCSP on July 1, 2025. With three months of the program now underway, the upcoming webinar will serve
- 김갑성 기자
- 2025-09-26 07:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-10-19_SUN

2025-10-18_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 19일 03시 20분